Table 2.
All patients (N = 4,222) | High risk (N = 3,783)a | CVD (N = 2,515) | Diabetes without CVD (N = 785) | SCORE risk ≥5% (N = 483) | SCORE risk <5% (N = 439) | |
---|---|---|---|---|---|---|
TC not at goal (%)b | 66.6 | 65.7 | 59.6 | 71.3 | 88.4 | 73.8 |
LDL-C not at goal (%)c | 58.1 | 58.1 | 52.7 | 61.3 | 83.3 | 58.7 |
Low HDL-C [<1.0 (men)/1.2 (women) mmol/L] (%)d | 22.7 | 23.1 | 24.8 | 24.0 | 12.9 | 18.7 |
Elevated TG (>1.7 mmol/L) (%)e | 47.3 | 47.5 | 45.9 | 54.3 | 44.6 | 45.2 |
aHigh risk = CVD, diabetes, and/or SCORE risk ≥5%
bTC ≥5 mmol/L in patients with SCORE risk <5%, and TC ≥4.5 mmol/L in patients with SCORE risk ≥5%, diabetes, and/or CVD. Data on 4,175 patients were available
cLDL ≥3 mmol/L in patients with SCORE risk <5%, and LDL ≥2.5 mmol/L) in patients with SCORE risk ≥5%, diabetes, and/or CVD. Data 3,887 patients were available
dData on 3,685 patients were available
eData on 3,727 patients were available